MerckMRK
MRK
0
Funds holding %
of 7,407 funds
0
Analysts bullish %
of 7 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
73% more first-time investments, than exits
New positions opened: 355 | Existing positions closed: 205
15% more call options, than puts
Call options by funds: $1.8B | Put options by funds: $1.56B
2% more funds holding
Funds holding: 3,441 [Q3] → 3,514 (+73) [Q4]
2.09% more ownership
Funds ownership: 75.58% [Q3] → 77.66% (+2.09%) [Q4]
10% less capital invested
Capital invested by funds: $218B [Q3] → $196B (-$21.2B) [Q4]
17% less repeat investments, than reductions
Existing positions increased: 1,293 | Existing positions reduced: 1,554
36% less funds holding in top 10
Funds holding in top 10: 111 [Q3] → 71 (-40) [Q4]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$96
21%
upside
Avg. target
$110
39%
upside
High target
$119
50%
upside
7 analyst ratings
4 positive
57%
3 neutral
43%
0 negative
0%
Deutsche Bank James Shin 0% 1-year accuracy 0 / 5 met price target | 33%upside $105 | Hold Downgraded | 18 Feb 2025 |
Guggenheim Vamil Divan 8% 1-year accuracy 2 / 26 met price target | 45%upside $115 | Buy Maintained | 12 Feb 2025 |
B of A Securities Tim Anderson 43% 1-year accuracy 6 / 14 met price target | 41%upside $112 | Buy Maintained | 5 Feb 2025 |
BMO Capital Evan David Seigerman 17% 1-year accuracy 3 / 18 met price target | 21%upside $96 | Market Perform Maintained | 5 Feb 2025 |
Citigroup Andrew Baum 20% 1-year accuracy 1 / 5 met price target | 45%upside $115 | Buy Maintained | 5 Feb 2025 |
Financial journalist opinion
Based on 324 articles about MRK published over the past 30 days
Neutral
Accesswire
16 hours ago
Levi & Korsinsky Reminds Merck & Co., Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 – MRK
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/merck-co-inc-lawsuit-submission-form?prid=142584&wire=1 or contact Joseph E. Levi, Esq.
Neutral
GlobeNewsWire
17 hours ago
Merck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; April 14, 2025 Deadline to file Lead Plaintiff Motion
Investors can contact the law firm at no cost to learn more about recovering their losses
Neutral
Accesswire
20 hours ago
April 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MRK
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/merck-co-inc-lawsuit-submission-form?prid=142552&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
21 hours ago
Merck & Co., Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - MRK
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/merck-co-inc-lawsuit-submission-form?prid=142540&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Business Wire
21 hours ago
Deadline Soon: Merck & Co (MRK) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming April 14, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Merck & Co (“Merck” or the “Company”) (NYSE: MRK) securities between February 3, 2022, to February 3, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON MERCK & CO (MRK), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAUD.
Negative
CNBC
22 hours ago
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages
President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told CNBC. The tariffs could disrupt the complex pharmaceutical supply chain, potentially driving up the prices of drugs in the U.S. and exacerbating shortages of critical medicine.
Neutral
Accesswire
1 day ago
Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/merck-co-inc-lawsuit-submission-form?prid=142428&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
1 day ago
MRK STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Merck & Co., Inc. ("Merck" or "the Company") (NYSE:MRK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Merck securities between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class Period").
Neutral
PRNewsWire
1 day ago
Investors who lost money on Merck & Co., Inc.(MRK) should contact Levi & Korsinsky about pending Class Action - MRK
NEW YORK , April 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") (NYSE: MRK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Merck investors who were adversely affected by alleged securities fraud between February 3, 2022 and February 3, 2025.
Neutral
Accesswire
1 day ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit - MRK
NEW YORK, NY / ACCESS Newswire / April 10, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/merck-co-inc-lawsuit-submission-form?prid=142362&wire=1 or contact Joseph E. Levi, Esq.
Charts implemented using Lightweight Charts™